Eli Lilly stock price forecast: bears dominate as LLY consolidates near 200-day support

Traders Union
All News
Companies
Eli Lilly drops 0.87% today

Highlights

LLY faces persistent short- and medium-term selling pressure, trading below key moving averages with strong downside momentum.
Momentum indicators confirm a bearish outlook, as oversold readings and negative signals dominate across all daily metrics.
Price is forecast to consolidate between $870 and $910, with downside risk if support at $870 breaks; upside capped by $950–$965 resistance.

LLY is trading at $889.24, notably below the MA-20 at $965.78 and MA-50 at $1,011.12, but just above the MA-200 at $895.30 on D1, indicating strong short- and medium-term selling pressure with some longer-term support from the MA-200. The Ichimoku Kijun (D1) sits at $980.03, which acts as immediate resistance; key resistance levels are marked by the MA-20 and Kijun cluster ($965.78–$980.03) and MA-50 at $1,011.12, while near-term support is found at the MA-200 ($895.30), with additional key support at lower weekly moving averages.

Momentum indicators show that both MACD and ADX on D1 signal a bearish trend, with MACD at -43.10 and weak directional strength from ADX (13.97). RSI (32.26), Stoch RSI (11.42), and CCI (-104.50) all register in oversold territory, confirming significant downside momentum. BBP is deeply negative at -21.72, showing that sellers are firmly in control. The Awesome Oscillator trend is neutral and does not reinforce the ongoing decline. Over the past week, LLY has fallen by $16.13 (1.69%) from a previous weekly close of $905.37, with weekly volatility at 3.48%. The price is now at the very bottom of its weekly range—confirming a steady, persistent selloff from recent highs.

For the coming week, the forecasted range for LLY is $870 to $910, reflecting the typical volatility for a blue-chip stock and keeping the price well above the 52-week low ($624.40) but below the peak ($1,133.95). The probability of a price increase is very low (less than 20%), with a much higher likelihood of further declines given the overwhelming bearish momentum across D1 and soft W1 signals (RSI and MA-50 on W1 both bearish, despite MACD on W1 showing "Strong Buy"). The baseline scenario sees LLY consolidating in the $870–$910 corridor. In a bullish case, a close above $910 may prompt a test of the $950–$965 resistance band. In a bearish scenario, failure to hold above $870 could trigger a move down to the $850s region. The overall risk is tilted to the downside, but the proximity to longer-term support could moderate further declines.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Eli Lilly showed ongoing technical uncertainty, with analysts highlighting the importance of key support levels for the stock’s near-term direction. In light of recent developments, investors should monitor if renewed momentum emerges, as a decisive move above resistance could signal the next trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.